Literature DB >> 29658186

Use of an In-line Digestive Cartridge With Enteral Nutrition Improves the Weight Trajectory of 2 Children With Cystic Fibrosis Complicated by Another Medical Diagnosis.

Catherine Giguere-Rich1, Amy Mathew2, Elizabeth Reid3, Kimberly Autore4, Margaret F Guill5.   

Abstract

This clinical observation describes the enteral nutrition (EN) management of 2 toddlers at high nutrition risk due to cystic fibrosis (CF), exocrine pancreatic insufficiency, and comorbid medical conditions. The first case report describes a boy with severe malabsorption after intestinal resection. The second case report reviews a boy with CF and neuroblastoma. When pancreatic enzyme replacement therapy with EN was not effective or appropriate, use of an in-line digestive cartridge was initiated. While using the digestive cartridge, both children showed improvements in their anthropometric measures. This observation reviews the nutrition management throughout their clinical course and describes the use of a digestive cartridge with EN.
© 2018 The Authors. Nutrition in Clinical Practice published by Wiley Periodicals, Inc. on behalf of American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  cystic fibrosis; enteral nutrition; exocrine pancreatic insufficiency; fat malabsorption; growth; pancrelipase; pediatrics; steatorrhea

Mesh:

Substances:

Year:  2018        PMID: 29658186     DOI: 10.1002/ncp.10080

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  3 in total

1.  Optimizing Clinical and Cost Outcomes for Patients on Enteral Nutrition Support for Treatment of Exocrine Pancreatic Insufficiency: Proceedings from an Expert Advisory Board Meeting.

Authors:  Joseph I Boullata; Janice L Clarke; Archie Stone; Alexis Skoufalos; David B Nash
Journal:  Popul Health Manag       Date:  2019-06       Impact factor: 2.459

2.  Improvements in anthropometric measures and gastrointestinal tolerance in patients with cystic fibrosis by using a digestive enzyme cartridge with overnight enteral nutrition.

Authors:  Sara J Hendrix; Patrick A Flume; Eric R First; Albert Archie Stone; Mark Van Buskirk
Journal:  Nutr Clin Pract       Date:  2022-02-24       Impact factor: 3.204

3.  Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding.

Authors:  John Stevens; Colby Wyatt; Perry Brown; Dhiren Patel; Danica Grujic; Steven D Freedman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-10       Impact factor: 2.839

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.